-
Mashup Score: 10
Increases in doctors’ bills, insurance and ‘lifestyle diseases’ are expected to boost hospital revenues
Source: www.ft.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 22023 Center for BRCA and Related Genes Scientific Symposium - 3 hour(s) ago
Select presentation from the 2023 Dana-Farber Cancer Institute Center for BRCA and Related Genes Scientific Symposium.
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
Researchers find instances of systems double-crossing opponents, bluffing, pretending to be human and modifying behaviour in tests
Source: www.theguardian.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 210Can large language models provide useful feedback on research... - 3 hour(s) ago
Expert feedback lays the foundation of rigorous research. However, the rapid growth of scholarly production and intricate knowledge specialization challenge the conventional scientific feedback…
Source: arXiv.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 215
A man acquitted of having a supporting role in the plot to kidnap Michigan Gov. Gretchen Whitmer says he’s running for county sheriff.
Source: apnews.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin for Adult Relapsed or Refractory B-Cell ALL - 4 hour(s) ago
This phase 1 dose-escalation trial examines whether inotuzumab ozogamicin plus dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (EPOCH) is safe and effective for adults with relapsed or refractory B-cell acute lymphoblastic leukemia or lymphoma (ALL).
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 134Duke & Duke Tee - 5 hour(s) ago
The Official Super 70s Sports Store
Source: www.super70ssportsstore.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5Overcoming barriers to single-cell RNA sequencing adoption in low- and middle-income countries - 5 hour(s) ago
European Journal of Human Genetics – Overcoming barriers to single-cell RNA sequencing adoption in low- and middle-income countries
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 149
PURPOSE Although chimeric antigen receptor T therapy (CAR-T) cells are an established therapy for relapsed/refractory multiple myeloma (RRMM), there are no established models predicting outcome to identify patients who may benefit the most from CAR-T. PATIENTS AND METHODS This is an international retrospective observational study including patients with RRMM infused with currently available commercial or academically produced anti–B-cell maturation antigen (BCMA) CAR-T. We describe characteristics and outcomes in Europe (n = 136) and the United States (n = 133). Independent predictors of relapse/progression built a simple prediction model (Myeloma CAR-T Relapse [MyCARe] model) in the training cohort (Europe), which was externally validated (US cohort) and tested within patient- and treatment-specific subgroups. RESULTS The overall response rate was 87% and comparable between both cohorts, and complete responses were seen in 48% (Europe) and 49% (the United States). The median time to r
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy - 5 hour(s) ago
The ‘Table 1 Fallacy’ refers to the unsound use of significance testing for comparing the distributions of baseline variables between randomised groups to draw erroneous conclusions about balance or imbalance. We performed a cross-sectional study of the Table 1 Fallacy in phase III oncology trials.
Source: www.ejcancer.comCategories: General Medicine News, Hem/OncsTweet
Private equity targets India’s hlthcare sector w/ record investments: Increases in Drs’ bills, insurance & ‘lifestyle diseases’ are expected to boost hospital revenues https://t.co/JGBY4GENu1 via @christopherkay @d_s_thakur @grumpeoldman @PriyankaPulla @RPrasad12 @RemaNagarajan